...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Voting

I didn't fully appreciate until now that Dr. Wong was still involved with Zenith after his exit from RVX management.

What are the current thoughts of him staying on with Zenith, but leaving RVX?

Just checking in this now, I also now realize that Zenith does not have a Chief Science Officer. At least, per the website. Was that always the case? I wonder why not?

Share
New Message
Please login to post a reply